Blend Labs, Inc. filings document the company’s digital banking origination business, operating results, governance, capital actions, and material corporate events. Form 8-K reports cover quarterly and annual financial results, supplemental Regulation FD materials, product and service disclosures, officer-transition matters, and board-authorized repurchases of Class A common stock.
Blend’s proxy materials describe annual meeting matters, board elections, executive compensation, stockholder voting procedures, and related governance disclosures. Recent filings also document completed corporate actions, including the sale of substantially all assets and liabilities of Title365 Company, Blend’s former title insurance business.
Form 4 Overview: Blend Labs, Inc. (BLND) filed a Form 4 disclosing that Brian Kneafsey, the company’s Head of Revenue, sold 20,000 shares of Class A common stock on 23 June 2025.
Transaction specifics: The disposition was coded “S” (open-market sale) and executed at a weighted-average price of $3.1657 per share, within a range of $3.12–$3.205. Following the sale, Kneafsey still beneficially owns 806,598 shares, indicating the transaction reduced his direct holdings by roughly 2.5%.
Rule 10b5-1 plan: The insider noted that the trade was carried out under a Rule 10b5-1 trading plan adopted on 14 March 2025. Pre-arranged plans can mitigate concerns about informational advantage because trades are scheduled in advance.
Ownership context: Kneafsey is classified as an Officer – Head of Revenue; no director or 10% ownership status was indicated. The filing is made by a single reporting person, and there are no derivative security transactions reported.
Investor takeaways: While any insider sale can draw attention, the size of this sale is modest relative to the insider’s remaining stake, and its execution under a 10b5-1 plan lessens potential negative signalling. No information about Blend Labs’ operational performance, earnings, or other corporate events is provided in this filing.
Form 144 Notice of Proposed Sale filed by Blend Labs (NYSE: BLND) on June 28, 2025, detailing insider trading activity. The filing indicates a proposed sale of 20,000 shares of common stock with an aggregate market value of $63,315 through Charles Schwab & Co.
Key transaction details:
- Securities were originally acquired on February 17, 2020, through an Exercise and Hold transaction
- Sale represents a small portion of total outstanding shares (254,775,978 shares)
- Planned execution date: June 23, 2025
- Previous insider activity: The seller (Brian Kneafsey) sold 45,000 shares on June 16, 2025, for gross proceeds of $145,268
The seller affirms no knowledge of undisclosed material adverse information regarding Blend Labs' operations. This Form 144 represents a declaration of intent to sell securities acquired through stock options, indicating potential insider sentiment.
Blend Labs, Inc. (BLND) has filed a Form 4 indicating that Head of Revenue Brian Kneafsey executed an insider sale on 16 June 2025. The filing shows a disposition of 45,000 Class A common shares at a weighted-average price of $3.2282 per share. The transaction was carried out under a Rule 10b5-1 trading plan adopted on 14 March 2025, signalling that the sale was pre-scheduled and designed to comply with SEC safe-harbor provisions.
Following the sale, Kneafsey’s direct beneficial ownership stands at 826,598 shares. No derivative security transactions were reported in this filing, and there are no indications of additional sales or purchases on the same date. The filing is signed by attorney-in-fact Winnie Ling on 18 June 2025.
While the transaction reduces the insider’s holdings by roughly 5% of his prior position (exact percentage not provided in the filing), the executive remains a significant shareholder. Investors often watch insider activity for sentiment signals; however, the presence of a 10b5-1 plan and the continued large stake suggest that this sale may be more about portfolio diversification or liquidity than a change in outlook.